Kips Bay Medical, Inc. (KIPS) announced on August 22nd/2012 that its U.S. feasibility trial (eMESH I) of the eSVS Mesh has commenced in Bern, Switzerland and anticipates first implants and enrollments under this study to begin the week of September 2, 2012. The objective of the eMESH I study remains the demonstration of initial safety [...]
NeoMedia Technologies (NEOM) yesterday announced that it has granted Microsoft a worldwide, non-exclusive, license to NeoMedia’s patent portfolio that consists of over 74 patents awarded and pending worldwide, encompasses many mobile barcode implementations used widely across the industry. (Note: no $$$ numbers have been mentioned). NeoMedia’s shares jumped over 120% on this announcement. NEOM reported [...]
Vision Plasma Systems (VLNX) and Continental Prison Systems (CPSZ) offer perfect swing trading opportunity while undervalued investments in Lpath (LPTN) and Implant Sciences (IMSC) are still on the verge of the major upcoming events. Vision Plasma Systems (VLNX) There is no secret what to expect from the multi-million promotional campaign on a company that operates [...]
ATP Oil & Gas Corp. (ATPG) stock gained today 19.5% after a loss of 74% on the Friday’s trading session. Company is in negotiation of a debtor-in-possession loan of $600 million that should be being provided by Credit Suisse Group AG. Will those funds been used for the ATP’s bankruptcy proceedings? Time will tell, so [...]
SPAR Group, Inc. (SGRP) today announced its financial results for the second quarter 2012. Company revenues were $24.3 million, with gross profit of $6.7 million and net income attributable to SPAR Group, Inc. of $718,000. For the six months of 2012 SPAR achieved revenue of $45.4 million, gross profit of $12.5 million and diluted earnings [...]
Echo Therapeutics, Inc. (Nasdaq: ECTE) today announced positive results from its clinical trial of the Symphony® tCGM System in major general surgery and cardiothoracic surgery for critically ill patients Continuously monitored glucose levels with Symphony® tCGM in the intensive care unit at Thomas Jefferson University Hospital in Philadelphia, ECTE’s Symphony System accurately read glucose levels with a [...]
Systems America, Inc. (SYAI) announced today after market hours that company received notice that Pink OTC Markets finished the processing the Company’s 2011 Annual Report and two reports for the quarters of 2012. As the result the Pink Sheets “Current Information” tier will be applied to the SYAI on July 25, 2012. Also Systems America is [...]
Galectin Therapeutics (GALT) develops carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the company’s unique approach of galectin proteins, key mediators of biologic function. Galectin announced today that it has received a notice of issuance from the U.S. Patent and Trademark Office for Patent Number 8,236,780. The patent covers key [...]
Astex Pharmaceuticals, Inc. (ASTX) today announced that Janssen-Cilag International NV, who holds marketing and development rights for DACOGEN™ in all markets except the North America, was notified that the CHMP (Committee for Medical Products for Human Use) of the EMA (European Medicines Agency) granted a positive opinion recommending approval of DACOGEN™ for injection in the [...]
pSivida Corp. (PSDV) today announced the National Security Agency of Medicines and Health Products (L’Agence Nationale de Sécurité du Médicament et des Produits de Santé) has granted marketing authorization to ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. Dr. Paul Ashton, President and [...]
